GeneDx Stock Quote WGS - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

83.76

Bid

83.75

Ask

84.01

Volume

1,189,862

81.82 Day's Range 92.97

2.85 52 Week Range 98.87

Market Cap

2.301B

Previous Close

89.38

Open

87.00

Last Trade

83.8648

Last Trade Time

15:15:04

Financial Volume

$ 102,490,691

VWAP

86.1366

Average Volume (3m)

629,455

Shares Outstanding

27,471,397

Dividend Yield

PE Ratio

-13.39

Earnings Per Share (EPS)

-6.4

Revenue

202.57M

Net Profit

-175.77M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. Show more

Sector

Blank Checks

Industry

Health Services

Website

www.genedx.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the NASDAQ with ticker WGS. The last closing price for GeneDx was $89.38. Over the last year, GeneDx shares have traded in a share price range of $ 2.85 to $ 98.87.

GeneDx currently has 27,471,397 shares outstanding. The market capitalization of GeneDx is $2.46 billion. GeneDx has a price to earnings ratio (PE ratio) of -13.39.

Overall Flow

Bullish

Net Premium

202k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

20.00%

Sweeps Ratio

0.00%

GeneDx Announces Preliminary 2024 Financial Results

Expects to exceed guidance with full year 2024 revenues1 of at least $299 million Expects fourth quarter 2024 revenues1 of at least $92 million Expects to exceed guidance with full year 2024...

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and test-ordering services for patients and...

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

Contributed nearly one quarter of all submissions to GeneMatcher and collaborated on more than 85 peer reviewed publications in 2024 GeneDx (Nasdaq: WGS), a leader in delivering improved health...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.49	5.66418569446	79.27	98.87	78.5	1049586	93.43945288	CS
4	7.805	10.2758212099	75.955	98.87	72.25	644846	83.93857412	CS
12	24.91	42.3279524214	58.85	98.87	55.3	629455	78.17494549	CS
26	50.57	152.365170232	33.19	98.87	25.84	544003	59.72148088	CS
52	80.15	2220.22160665	3.61	98.87	2.85	463398	42.30225808	CS
156	72.837	666.822301566	10.923	98.87	1.16	939369	19.38128493	CS
260	72.837	666.822301566	10.923	98.87	1.16	939369	19.38128493	CS

WGS - Frequently Asked Questions (FAQ)

What is the current GeneDx share price?

The current share price of GeneDx is $ 83.76

How many GeneDx shares are in issue?

GeneDx has 27,471,397 shares in issue

What is the market cap of GeneDx?

The market capitalisation of GeneDx is USD 2.46B

What is the 1 year trading range for GeneDx share price?

GeneDx has traded in the range of $ 2.85 to $ 98.87 during the past year

What is the PE ratio of GeneDx?

The price to earnings ratio of GeneDx is -13.39

What is the cash to sales ratio of GeneDx?

The cash to sales ratio of GeneDx is 11.62

What is the reporting currency for GeneDx?

GeneDx reports financial results in USD

What is the latest annual turnover for GeneDx?

The latest annual turnover of GeneDx is USD 202.57M

What is the latest annual profit for GeneDx?

The latest annual profit of GeneDx is USD -175.77M

What is the registered address of GeneDx?

The registered address for GeneDx is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the GeneDx website address?

The website address for GeneDx is www.genedx.com

Which industry sector does GeneDx operate in?

GeneDx operates in the HEALTH SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PHIOPhio Pharmaceuticals Corporation	$ 7.18 (324.85%)	265.54M
SLRXSalarius Pharmaceuticals Inc	$ 4.005 (155.91%)	113.72M
ATPCAgape ATP Corporation	$ 2.03 (61.11%)	82.3M
VRMEVerifyMe Inc	$ 3.9501 (54.91%)	53.69M
XXII22nd Century Group Inc	$ 6.798 (39.02%)	22.56M
EHGOEshallgo Inc	$ 1.29 (-60.55%)	5.61M
CMTLComtech Telecommunications Corporation	$ 2.28 (-44.79%)	3.8M
HUBCWHub Cyber Security Ltd	$ 0.0176 (-41.33%)	265.23k
SVMHSRIVARU Holding Ltd	$ 0.0364 (-41.10%)	162.57M
GRNQGreenpro Capital Corporation	$ 1.12 (-40.74%)	2.58M
GCTKGlucoTrack Inc	$ 0.136701 (16.84%)	645.39M
PHIOPhio Pharmaceuticals Corporation	$ 7.18 (324.85%)	265.54M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0632 (-28.26%)	179.41M
SVMHSRIVARU Holding Ltd	$ 0.0364 (-41.10%)	162.57M
NVDANVIDIA Corporation	$ 132.1893 (-2.74%)	160.47M